To examine the relevance of HO-1 in human metastatic disease, we performed in silico Oncomine database analyses of several prostate datasets and determined that expression of this enzyme is higher in metastatic tissues than primary tumors from prostate cancer patients (Fig. 1C). Here, HMOX1 is linked to prostate cancer.